Table 1. Patient characteristics . NST... | American Society of Hematology

Table 1.

Patient characteristics

	NST group	Auto-SCT group	P
No.	9	26	NA
No. male/no. female	7/2	21/5	NS*
Age, y (range)	53 (40-63)	51 (34-60)	NS†
V_H homology, % (range)	100 (99.6-100)	100 (98.3-100)	NS†
FISH del 11q23 or del 17p13 (%)	3/8 (38)	8/23 (35)	NS*
Lymphocyte doubling time less than 12 mos. (%)	5/7 (71)	14/17 (82)	NS*
Binet stage B/C, no. (%)	8 (89)	17 (68)	NS*
Time to ASCT, mos. (range)	44 (8-129)	12 (3-117)	.01†
No. of previous regimens (range)	4 (1-6)	2 (1-4)	.009†

	NST group	Auto-SCT group	P
No.	9	26	NA
No. male/no. female	7/2	21/5	NS*
Age, y (range)	53 (40-63)	51 (34-60)	NS†
V_H homology, % (range)	100 (99.6-100)	100 (98.3-100)	NS†
FISH del 11q23 or del 17p13 (%)	3/8 (38)	8/23 (35)	NS*
Lymphocyte doubling time less than 12 mos. (%)	5/7 (71)	14/17 (82)	NS*
Binet stage B/C, no. (%)	8 (89)	17 (68)	NS*
Time to ASCT, mos. (range)	44 (8-129)	12 (3-117)	.01†
No. of previous regimens (range)	4 (1-6)	2 (1-4)	.009†

NS indicates not significant (significance level = .05); NA, not applicable.

Determined using 2-tailed Fisher exact test.

Determined using 2-tailed Mann-Whitney test.